← Back to Research Radar
Academic Publication Academic Publication

Artificial intelligence in drug development

509
Citations
January 1, 2025
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
23%

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including machine learning, deep learning, and other advance...

crossref.org › academic paper
0%

Artificial intelligence in drug development

No description provided.

crossref.org › academic paper
0%

A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation

Abstract Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug design process, with various generative models already in widespread use. Generat...

crossref.org › academic paper
0%

Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides

Abstract With their diverse biological activities, peptides are promising candidates for therapeutic applications, showing antimicrobial, antitumour and hormonal signalling capabilit...

crossref.org › academic paper
0%

ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries

Abstract Motivation The emergence of large chemical repositories and combinatorial chemical spaces, coupled with high-throughput docking a...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Artificial intelligence in drug development'?

This literature focuses on:

Are there open-source GitHub repositories related to Artificial intelligence in drug development?

Yes, open-source projects like BigBodyCobain/Shadowbroker (Open-source intelligence for the global theater. Track everything from the corporate/private jets of the wealthy, and spy satellites, to seismic ev...) are actively building upon these concepts.

Which startups are commercializing the technology behind Artificial intelligence in drug development?

Products like JusticeFlow - AI-Powered Legal Practice are bringing this to market. Their focus is: Legal Practice Management with AI-Powered Intelligence.

What other academic literature is closely related to 'Artificial intelligence in drug development'?

Yes, highly correlated activity was mapped. An entry titled 'Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine' discusses this: Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including ...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Enterprise Ecosystem Mentions

Associated Media Narrative